Arlene Chapman to Patient Safety
This is a "connection" page, showing publications Arlene Chapman has written about Patient Safety.
Connection Strength
0.123
-
Rationale and Design of a Clinical Trial Investigating Tolvaptan Safety and Efficacy in Autosomal Dominant Polycystic Kidney Disease. Am J Nephrol. 2017; 45(3):257-266.
Score: 0.123